Lysophospholipids as Biomarkers of Ovarian Cancer

A method of using a bioactive lysophospholipid (LL) as a biomarker for detecting the presence and recurrence of ovarian cancer. Subspecies of LL, such as lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI), lysophosphatidylcholine (LPC), and lysosphingolipid sphinsosine-1-phosphate (S1P), are used alone or in conjunction to increase the specificity and sensitivity of the assay.

Patents:
US 7,964,408 issued 2011-07-21   [MORE INFO]

Inventor(s): SUTPHEN REBECCA [US]

Type of Offer: Licensing



« More Biotech Patents

---